Pharmaceuticals, Biotechnology and Life Sciences
Vertex Pharmaceuticals Incorporated today announced the results of a Phase 3 study of Orkambi (lumacaftor/ivacaftor) in children with cystic fibrosis…
Horizon Pharma has announced its third-quarter 2016 financial results on Monday.
Neovacs, a player in active immunotherapy for the treatment of autoimmune diseases, has enroled the first U.S. patient in its international Phase IIb clinical study of IFNalpha Kinoid in lupus.
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…
Mereo BioPharma has appointed Richard CM Jones as Chief Financial Officer
The first data analysis of the NKR-2 Phase I trial, run by the Belgia’s biopharmaceutical company Celyad, shows encouraging results
Surgical Innovations Group has completed the acquisition of the laparoscopic instruments …
Professor Gerard Evan, FRS, has joined Scientific Advisory Board of Avacta Group, the developer of Affimer biotherapeutics and research reagents.
Two prominent U.S. lawmakers on Thursday called on federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co, Merck…
The primary objective is to determine the effect of daily oral administration of elafibranor on serum alkaline phosphatase (ALP) in these patients, based on relative change versus placebo.